mTOR pathway activation drives lung cell senescence and emphysema

Area of Science:

• Pulmonary Medicine
• Cellular Biology
• Molecular Signaling

Background:

• Chronic obstructive pulmonary disease (COPD) is a widespread, severe respiratory disease with no cure.
• Accumulated lung cell senescence is a potential key factor in COPD pathogenesis.
• The role of mTOR signaling in COPD-related lung cell senescence requires further investigation.

Purpose of the Study:

• To investigate the involvement of mTOR signaling in lung cell senescence within COPD.
• To determine if mTOR activation is a causal factor in COPD development and associated lung alterations.
• To explore the therapeutic potential of targeting the mTOR pathway in COPD.

Main Methods:

• Analysis of lung tissue and cultured cells from COPD patients and control smokers.
• Assessment of mTOR signaling activation and cell senescence markers.
• Development and utilization of transgenic mouse models with targeted mTOR overactivity.
• Evaluation of COPD-like lung alterations, including emphysema, pulmonary hypertension, and inflammation, in mouse models.

Main Results:

• Cellular senescence in COPD lungs correlated with increased mTOR signaling.
• Inhibition of mTOR with low-dose rapamycin reduced lung cell senescence and the senescence-associated secretory phenotype.
• Transgenic mice with overactive mTOR in lung cells developed COPD-like lung emphysema, pulmonary hypertension, and inflammation.
• mTOR activation was demonstrated to be sufficient to induce lung cell senescence and mimic COPD pathology.

Conclusions:

• mTOR pathway activation is causally linked to lung cell senescence and the development of COPD-associated lung alterations.
• Targeting the mTOR pathway represents a promising therapeutic strategy for COPD.
• Further research into mTOR inhibition could lead to novel treatments for patients with COPD.